bromocriptine has been researched along with gbr 12935 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allard, P; Eriksson, K; Marcusson, JO; Ross, SB | 1 |
Cumps, J; Geurts, M; Hermans, E; Maloteaux, JM | 1 |
Geurts, M; Maloteaux, JM; Noël, F | 1 |
3 other study(ies) available for bromocriptine and gbr 12935
Article | Year |
---|---|
Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
Topics: Animals; Binding, Competitive; Bromocriptine; Cocaine; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Haloperidol; Kinetics; Male; Piperazines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides | 1990 |
Dopamine receptor-modulated [35S]GTPgammaS binding in striatum of 6-hydroxydopamine-lesioned rats.
Topics: Animals; Apomorphine; Benzazepines; Bromocriptine; Cell Membrane; Corpus Striatum; Domperidone; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Male; Oxidopamine; Piperazines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulfur Radioisotopes; Tritium | 1999 |
Selective destruction of nigrostriatal dopaminergic neurons does not alter [3H]-ryanodine binding in rat striatum.
Topics: Adrenergic Agents; Animals; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agonists; Male; Neuroleptic Malignant Syndrome; Neurons; Oxidopamine; Piperazines; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Substantia Nigra | 2000 |